The article was professionally consulted by Specialist Doctor II Nguyen Quoc Viet - Department of Medical Examination & Internal Medicine - Vinmec Danang International General Hospital. The doctor has more than 20 years of experience in the examination and treatment of cardiovascular diseases and Interventional Cardiology.
Pulmonary hypertension is a disease that can occur at any age, from infants to the elderly. Currently, pulmonary hypertension cannot be completely cured but can only be treated to reduce the symptoms of the disease.
1. What is pulmonary hypertension?
Pulmonary hypertension is an abnormal increase in pulmonary arterial pressure that may result from left heart failure, damage to the lung parenchyma, or from vascular disease, thromboembolism, or a combination of the above factors. Normal pulmonary arterial pressure at rest is 15 mmHg, and it increases by 1 mmHg every year, when mean adult pulmonary artery pressure is > 25 mmHg (at rest) it is considered hypertension. pulmonary artery.
2. What are the symptoms of pulmonary hypertension?
Symptoms of non-specific pulmonary hypertension include: dyspnea, fatigue, weakness, chest pain, syncope, and abdominal distension. Symptoms at rest only appear when the disease is severe, including: distended neck veins, hepatomegaly, peripheral edema, ascites, and cold extremities.
3. Is pulmonary hypertension dangerous?
Pulmonary hypertension if not treated aggressively, promptly and eliminated the causes of the disease, hypertension can cause dangerous complications, causing sudden death such as: Causes right heart failure, prognosis The amount is often very severe and can easily lead to death. Increases the likelihood of blood clots forming in the pulmonary arteries, causing pulmonary infarction, if the clots cause narrowing or blockage of large blood vessels, shock and death can occur. Pulmonary artery rupture Causing arrhythmia Compression of the coronary artery stem due to pulmonary artery dilatation Coughing up blood can be life-threatening (due to bronchial artery rupture). Recent studies have demonstrated that clinical health risks associated with mean pulmonary arterial pressures (PAPs) can begin to emerge from values > 19 mmHg, which is lower than the threshold. Commonly used to determine Pulmonary Hypertension (PH) is 25 mmHg. The risk of death is increased in patients with mild pulmonary hypertension, defined as mean pulmonary arterial pressure >19 mmHg. These data highlight the need for early diagnosis of patients with mild pulmonary hypertension to be considered for inclusion in studies. This contributes to finding future drug and non-drug interventions to reduce health risks and improve outcomes.
5. Recommendations for patients with pulmonary hypertension
Patients with pulmonary hypertension should avoid pregnancy. Strengthening immunity against influenza and pneumonia in patients with pulmonary hypertension. Psychological support for patients with pulmonary hypertension. Exercise monitoring in patients with pulmonary hypertension. If the patient is traveling by plane, oxygen support is required when the hemodynamic blood pressure is <8 kPa (<60 mmHg). During surgery, spinal anesthesia should be performed rather than general anesthesia. Treatment of anemia or iron deficiency in patients with pulmonary hypertension. Physical activity that causes symptoms is not recommended. Vinmec has a team of specialists in Cardiology who are professors, doctors, specialists with high expertise and experience at home and abroad. Besides, Vinmec constantly invests and upgrades the system of modern and modern equipment and machines to support the diagnosis and treatment. Vinmec medical system is managed and operated according to international standards across the country, is a reliable medical examination and treatment address, where customers receive medical services with the highest satisfaction.
Để đặt lịch khám tại viện, Quý khách vui lòng bấm số
hoặc đặt lịch trực tiếp TẠI ĐÂY.
Tải và đặt lịch khám tự động trên ứng dụng MyVinmec để quản lý, theo dõi lịch và đặt hẹn mọi lúc mọi nơi ngay trên ứng dụng.
Kelabto là thuốc ức chế Phosphodiesterase typ 5. Thuốc có dạng viên nén bao phim. Tuân thủ chỉ định, liều dùng thuốc Kelabto sẽ giúp người bệnh nâng cao hiệu quả điều trị và tránh được những tác dụng phụ ...
Safebo thuộc nhóm thuốc tim mạch, được bào chế dưới dạng viên nén bao phim, quy cách đóng gói hộp 1 vỉ x 10 viên. Thành phần chính trong thuốc Safebo là hoạt chất Bosentan (dưới dạng Bosentan monohydrat) 62.5mg. ...